NCT05468931
Prostate Stimulation for Sexual Dysfunction
At risk: Primary completion moved 12 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 8 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jun 1, 2026 to Jun 1, 2027
- Eligibility criteria expanded, about 5 words
- Notable Primary and study completion dates: Jun 1, 2025 to Jun 1, 2026v7
- Minor Start date changed from estimate of Apr 25, 2024 to Apr 18, 2024v6
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary and study completion dates: Jun 1, 2024 to Jun 1, 2025
- Start date: Dec 1, 2023 to Apr 25, 2024
- Site details revised
- Notable Start date: Jun 1, 2023 to Dec 1, 2023v4
Show 2 earlier versionsHide 2 earlier versions
- Notable Primary and study completion dates: Jun 1, 2023 to Jun 1, 2024
- Start date: Dec 1, 2022 to Jun 1, 2023
- Notable Start date: Sep 1, 2022 to Dec 1, 2022v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
change in modified International Index of Erectile Dysfunction score
Timeframe: baseline and up to 1 month post-baseline
Arms and interventions
Prostate stimulation device armExperimental
Participants will be asked to use our prostate stimulation device.
Devices: Prostate stimulator
Sites
1 site in 1 country
- Stanford Healthcare, Stanford HospitalStanford, California, United States